261635-82-9

Upstream product

• 194673-13-7 ethyl 6-hydroxy-2-(trifluoromethyl)pyridine-3-carboxylate 
• 770-12-7 O-phenyl phosphorodichloridate 
• 372-31-6 ethyl 4,4,4-trifluoroacetoacetate 
• 194673-12-6 ethyl 2-hydroxy-6-(trifluoromethyl)-3,4-dihydropyridine-5-carboxylate 
• 208517-35-5 ethyl 2-(trifluoromethyl)pyridine-3-carboxylate 

Downstream Products

• 676627-03-5 6-(3-chloro-phenylamino)-2-trifluoromethyl-nicotinic acid ethyl ester 
• 117519-13-8 6-chloro-2-(trifluoromethyl)pyridin-3-amine 
• 676627-04-6 6-(3-chloro-phenylamino)-2-trifluoromethyl-nicotinic acid hydrochloride 
• 676993-98-9 6-(3-chloro-phenylamino)-N-(pyridin-4-ylmethyl)-2-trifluoromethyl-nicotinamide 
• 1080631-74-8 ethyl 6-{3-[3,5-bis-(trifluoromethyl)phenyl]-3-(trifluoromethyl)pyrrolidin-1-yl}-2-(trifluoromethyl)nicotinate 
• 1365356-72-4 N-{[6-{4-[3,5-bis(trifluoromethyl)phenyl]-2-hydroxy-4-(trifluoromethyl)pyrrolidin-1-yl}-2-(trifluoromethyl)pyridin-3-yl]methyl}propanamide 
• 1365264-92-1 N-{[6-{4-[3,5-bis(trifluoromethyl)phenyl]-2-oxo-4-(trifluoromethyl)pyrrolidin-1-yl}-2-(trifluoromethyl)pyridin-3-yl]methyl}propanamide 
• 1080630-04-1 N-{[6-{3-[3,5-bis(trifluoromethyl)phenyl]-3-(trifluoromethyl)pyrrolidin-1-yl}-2-(trifluoromethyl)pyridin-3-yl]methyl}propanamide 
• 1221695-24-4 1-[6-{3-[3,5-bis(trifluoromethyl)phenyl]-3-(trifluoromethyl)pyrrolidin-1-yl}-2-(trifluoromethyl)pyridin-3-yl]methanamine 
• 1221785-18-7 [6-{3-[3,5-bis-(trifluoromethyl)phenyl]-3-(trifluoromethyl)pyrrolidin-1-yl}-2-(trifluoromethyl)pyridin-3-yl]methanol 
• 261635-83-0 6-chloro-2-(trifluoromethyl)pyridine-3-carboxylic acid 

Relevant academic research and scientific papers

COMPOUNDS THAT MODULATES AMPA RECEPTOR FUNCTION

The invention provides compounds of the formula (I): (I) wherein A1, A2, R2, R4, B1, B2, X, X1, n, a and b are as defined are defined in the specification, to pharmaceutical comp

COMBINATION OF CB2 MODULATORS AND PDE4 INHIBITORS FOR USE IN MEDICINE

Combination of one or more CB2 modulators such as a compound of formula (I), (II) and (III); and one more PDE4 inhibitors are useful of treating conditions which are mediated by the activity of CB2 receptors or conditions which are mediated by PDE4, such

PYRIDINE DERIVATIVES AS CB2 RECEPTOR MODULATORS

The present invention relates to novel pyridine derivatives of formula (I) pharmaceutical compositions containing these compounds and their use in the treatment of diseases, particularly pain, which diseases are caused directly or indirectly by an increas

PYRIDINE DERIVATIVES AS CB2 RECEPTOR MODULATORS

The present invention relates to novel pyridine derivatives, pharmaceutical compositions containing these compounds and their use in the treatment of diseases, particularly pain, which diseases are caused directly or indirectly by an increase or decrease